Physician profile
John P Tuttle
NPI 1396728358
$1,876.33
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $725 · 2020: $409 · 2021: $494 · 2022: $249.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $932.66 | 2019-2022 | |
| Antares Pharma, INC. | $224.84 | 2019-2022 | |
| Duchesnay USA Incorporated | $132.71 | 2019 | |
| Coloplast Corp | $60.35 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.11 | 2021-2022 | |
| Janssen Biotech, INC. | $54.30 | 2021-2022 | |
| Pfizer INC. | $53.72 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $50.02 | 2021-2022 | |
| Urovant Sciences INC | $48.17 | 2022 | |
| Ferring Pharmaceuticals INC. | $43.57 | 2019 | |
| Myovant Sciences INC. | $38.72 | 2021 | |
| Allergan, INC. | $27.42 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $22.95 | 2021 | |
| Neotract INC. | $18.05 | 2019 | |
| Accord Healthcare, INC. | $17.55 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $17.05 | 2021 | |
| Clarus Therapeutics INC. | $15.00 | 2021 | |
| Karl Storz Endoscopy-America | $13.78 | 2019 | |
| Boston Scientific Corporation | $12.70 | 2022 | |
| Medtronic USA, INC. | $12.66 | 2020 | |
| Amag Pharmaceuticals, INC. | $11.91 | 2019 | |
| Abbvie INC. | $11.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Tuttle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.